Features Practice Technique
Free Webinar from Metagenics

The
discussion will include using a whole systems approach entitled “Scientific Breakthroughs in
the Natural Management of Menopausal Symptoms.” The Metagenics
University webinar will be presented by Deanna Minich, PhD, FACN, CNS, vice
president of scientific affairs at Metagenics.

An
estimated 6,000 women in the U.S. reach menopause every day (two million
annually). But symptoms typically begin in the phase known as perimenopause,
which can last anywhere from two to 10 years. A wide range of vasomotor,
physical, and psychological symptoms can negatively affect a woman’s quality of
life on a daily basis in perimenopause and well into postmenopause.

“Topping
the list of menopausal complaints are hot flashes and night sweats, two
vasomotor symptoms that can occur any time of day. Some women may experience 10
or more moderate to severe hot flashes in a single day," said Dr. Minich,
who is a practicing research clinician and frequently lectures to professionals
on advancements in women’s health approaches. “Well-designed clinical studies
have demonstrated that a novel rhubarb extract known as 
ERr 731 provides
effective relief for menopausal hot flashes that is comparable to conventional
hormone therapies, but without the associated potential for serious adverse
events.”

Due to
their well-known risks, hormone therapies are not recommended as a long-term
approach—and are primarily indicated for moderate to severe vasomotor symptoms
in postmenopausal women under age 60. And natural approaches—such as soy/clover
isoflavones, hops, flax lignans or black cohosh—may offer a higher degree of
safety for both peri- and postmenopausal use, but have shown a varying degree
of clinical success and lack adequate scientific support that demonstrates a
high degree of efficacy.

The
webinar will include a discussionon about ERr 731, one of the most thoroughly
researched phytoestrogen selective estrogen receptor modulators (phytoSERMs) to
date. ERr 731 is a novel extract of Siberian rhubarb root and the key
ingredient in Metagenics’ Estrovera dietary supplement. In published clinical
studies, ERr 731 has been shown to:

• Significantly reduce the
  number and severity of menopausal hot flashes and night sweats compared to
  placebo
• Significantly relieve
  (compared to placebo) a wide range of other menopausal symptoms, including
  sleep disturbances, poor mood, physical and emotional exhaustion,
  joint and muscle complaints, and urogenital symptoms
• Be well-tolerated and produce
  no clinically relevant changes in safety parameters—including
  gynecological findings, vital parameters, and laboratory safety parameters
  after 108 weeks of clinical observation.